Xianling H. Liu
139 Middle Renmin Road
Changsha, 410011, China
Changsha, 410011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 97 publications
DNA hypomethylation identifying clinical benefit subgroup of small-cell lung cancer: multi-omics analysis of a phase II trial with durvalumab plus olaparib as maintenance therapy.
Journal: Journal for immunotherapy of cancer
Published: August 05, 2026
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: July 08, 2026
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR-Variant Non-Small Cell Lung Cancer: The HARMONi-A Randomized Clinical Trial.
Journal: JAMA
Published: June 17, 2026
Phase Ib Trial of Finotonlimab Combined With SCT200 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Journal: Cancer medicine
Published: November 10, 2025
A multi-omics approach elucidates the link between artificial food colorings and common cancers.
Journal: Frontiers in nutrition
Published: November 10, 2025
Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer.
Journal: The New England journal of medicine
Published: October 22, 2025
Enzyme-powered micellar nanoreactors enable tumor-specific, cascade-amplified prodrug activation for synergistic oxidation-chemo-immunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 30, 2025
Retraction Note: The microRNA-130a-5p/RUNX2/STK32A network modulates tumor invasive and metastatic potential in non-small cell lung cancer.
Journal: BMC cancer
Published: July 22, 2025
Semi-permeable polymer vesicle-based prooxidative and lactate-depleting nanoreactors with sustained activity against pancreatic cancer.
Journal: Frontiers in bioengineering and biotechnology
Published: May 12, 2025
Global research trends and focus on biomarkers in lung cancer immunotherapy: a comprehensive bibliometric insight and visualization analysis (2001-2025).
Journal: Frontiers in immunology
Published: May 03, 2025
CD33 drives cutaneous melanoma: mendelian randomization confirms causality, multi-omics and in vitro experiments reveal M2 macrophage polarization-mediated progression.
Journal: International journal of surgery (London, England)
Published: April 25, 2025
Last Updated: 09/26/2026